Eversheds Sutherland has advised the EIC Fund

Stethoscope lying on the tablet computer in front of a doctor and patient sitting opposite each other at the background . Medicine, healthcare concept.Stethoscope lying on the tablet computer in front of a doctor and patient sitting opposite each other at the background . Medicine, healthcare concept.

Eversheds Sutherland has advised the EIC Fund

January 16, 2024

Sweden
Sweden
Sweden
Eversheds Sutherland has advised the European Innovation Council Fund (EIC Fund) in connection with a funding round in CYTO365 AB. 
 
CYTO365 AB is a medtech company and has received financing from the EIC Fund for its business to develop and launch their product RondelO™. This product prevents infusion therapy drugs accidentally being mixed and combats drug incompatibility by design, and it is the only physical device that adds an extra layer of safety for the handling and administration of drugs to the patient.
 
This transaction is part of the long-term collaboration agreement between Eversheds Sutherland and the EIC Fund.
 
Eversheds Sutherland's team consisted of Gabriel Albemark, Joel Olsson and Therése Berg.
The materials on the Eversheds Sutherland website are for general information purposes only and do not constitute legal advice. While reasonable care is taken to ensure accuracy, the materials may not reflect the most current legal developments. Eversheds Sutherland disclaims liability for actions taken based on the materials. Always consult a qualified lawyer for specific legal matters. To view the full disclaimer, see our Terms and Conditions or Disclaimer section in the footer.

Services

Key contacts

gabrielalbemark@eversheds-sutherland.se Headshot Headshot Headshot

Gabriel Albemark

Partner

Stockholm, Sweden

thereseberg@eversheds-sutherland.se Portrait Carousel

Therése Berg

Associate

Stockholm, Sweden

Latest Insights

Latest News

Latest Events

modern office interior glass ceiling architectural lines corporate building

legal updates

June 04, 2026

FS+ Country Updates – May 2026

Generic building in front of sun (1)

legal updates

June 03, 2026

Global Life Sciences & Healthcare Bulletin

glass facade building reflection blue sky modern corporate architecture

legal updates

June 03, 2026

Commercially Connected shorts - 3 June 2026

shopping district

legal updates

May 29, 2026

Consumer Lens - Session 1 | The Rise of European Class Actions

© Eversheds Sutherland 2026. All rights reserved. Eversheds Sutherland is a provider of legal and other services operating through various separate and distinct legal entities. For further information about these entities and Eversheds Sutherlands' structure please see the Legal Notice page of this website.

Eversheds Sutherland is the name and brand under which the members of Eversheds Sutherland Limited (Eversheds Sutherland (International) LLP and Eversheds Sutherland (US) LLP) and their respective controlled, managed and affiliated firms and the members of Eversheds Sutherland (Europe) Limited (each an "Eversheds Sutherland Entity" and together the "Eversheds Sutherland Entities") provide legal or other services to clients around the world. Eversheds Sutherland Entities are constituted and regulated in accordance with relevant local regulatory and legal requirements and operate in accordance with their locally registered names. The use of the name Eversheds Sutherland, is for description purposes only and does not imply that the Eversheds Sutherland Entities are in a partnership or are part of a global LLP. The responsibility for the provision of services to the client is defined in the terms of engagement between the instructed firm and the client. For further information about these Eversheds Sutherland Entities and Eversheds Sutherlands’ structure please see the Legal Notices page of this website.